BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 23215828)

  • 1. Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative cases.
    Bergman P; Brodin D; Lewensohn R; de Petris L
    Acta Oncol; 2013 Aug; 52(6):1189-94. PubMed ID: 23215828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer.
    Kudo Y; Saji H; Shimada Y; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Lung Cancer; 2013 Aug; 81(2):187-93. PubMed ID: 23664031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
    Christian C; Erica S; Morandi U
    Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
    Ruffini E; Asioli S; Filosso PL; Buffoni L; Bruna MC; Mossetti C; Solidoro P; Oliaro A
    J Thorac Oncol; 2011 Feb; 6(2):319-26. PubMed ID: 21164365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
    Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
    Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of reclassification from the TNM-6 into the TNM-7 staging system in bronchoplastic resection for non-small cell lung cancer.
    Klikovits T; End A; Riedl G; Stiebler M; Dekan G; Klepetko W
    Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):29-34. PubMed ID: 21525027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer.
    Kikuchi S; Futawatari N; Sakuramoto S; Katada N; Yamashita K; Shibata T; Nemoto M; Watanabe M
    Anticancer Res; 2011 Jun; 31(6):2361-5. PubMed ID: 21737665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
    Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
    Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of 7th TNM staging system for lung cancer, based on surgical outcomes.
    Yoshida Y; Murayama T; Sato Y; Suzuki Y; Saito H; Tanaka N
    Asian Cardiovasc Thorac Ann; 2013 Dec; 21(6):693-9. PubMed ID: 24569328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
    Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer].
    Hosokawa Y; Matsuge S; Murakami Y; Satoh K; Yamazaki S; Kan T; Hatakeyama H
    Kyobu Geka; 2000 Oct; 53(11):910-4. PubMed ID: 11048440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
    Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
    J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
    Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of the use of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers.
    Lyons G; Quadrelli S; Jordan P; Colt H; Chimondeguy D
    Lung Cancer; 2011 Nov; 74(2):244-7. PubMed ID: 21411177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
    Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.
    Turk F; Gursoy S; Yaldiz S; Yuncu G; Yazgan S; Basok O
    Minerva Chir; 2011 Dec; 66(6):509-16. PubMed ID: 22233657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.